Research
UNMC History 101 – Happy 50th Eppley Institute!
The Eppley Institute for Research in Cancer and Allied Diseases — or simply the Eppley Institute as it’s commonly called on campus — celebrates its 50th anniversary this week.
Sep 6, 2011
Call for FIRST Award pre-proposals
Pre-proposals for Nebraska EPSCoR’s FIRST Award grant program are due by 5 p.m., Monday, Oct. 3.
Aug 29, 2011
Research looks to simplify HIV treatment
UNMC researchers have made strides on a new therapy that would allow patients with HIV to receive a weekly injection rather than take daily a regimen of pills to manage their disease.
Aug 25, 2011
Foundation grants support research collaboration in China, India
International research programs at UNMC focused on diabetes, environmental health factors and lymphoma have received support through $250,000 in grant awards from the University of Nebraska Foundation.
Aug 24, 2011
UNMC researchers developing more effective drug delivery for HIV
Dr. Gendelman lands $4.6 million NIH grant
Aug 24, 2011
Study shows therapy effectively prevents HIV
UNMC’s Susan Swindells, M.B.B.S., participated in study detailed in New England Journal of Medicine that showed that HIV infection in the HIV-negative person can be prevented by giving antiretroviral therapy to the HIV-positive person.
Aug 17, 2011
Dr. Susan Fritz named NU associate vice president-academic affairs
Susan Fritz, Ph.D., a longtime University of Nebraska-Lincoln faculty member and administrator, has been named associate vice president-academic affairs in the Office of the Provost at the University of Nebraska.
Aug 16, 2011
Antiretroviral therapy effective in preventing HIV infection
UNMC researcher participates in study detailed in New England Journal of Medicine
Aug 16, 2011
Shared Resource/Core Facility Day set for Sept. 20
The fourth biennial “Shared Resource/Core Facility Day” will be held Sept. 20 from 11 a.m. to 1 p.m. in the Interaction Space between the Durham Research Centers.
Aug 16, 2011
Study looks to limit use of powerful antibiotic
The use of vancomycin — a powerful antibiotic often considered the last resort in the treatment of bacterial infections — is a focal point of a clinical study at UNMC and other medical centers in the U.S. and Europe.
Aug 10, 2011
